Preserving fertility preservation in cancer patients;Fertilitätserhalt bei onkologischen patientinnen: Stand und perspektiven

Deutsches Arzteblatt

Volumn 103, Issue 38, 2006, Pages

  Von Otte, Sören ^a   Friedrich, Michael ^a   Diedrich, Klaus ^a   Kupka, Markus ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Assisted reproduction; Cancer therapy; Cryopreservation; Fertility; GnRH

Indexed keywords

BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; MELPHALAN; METHOTREXATE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; CRYOPRESERVATION; FERTILITY; HUMAN; OOCYTE; OVARY FUNCTION; OVARY INSUFFICIENCY; PRESERVATION; ZYGOTE;

EID: 33750086022     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Robert-Koch-Institut: Arbeitsgemeinschaft bevölkerungsbezogener Krebsregister in Deutschland 2004; 4. Auflage, Berlin.
2. Leung W, Hudson MM, Strickland DK et al.: Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000; 18: 3273-9.
3. Shusterman S und Meadows AT: Long term survivors of childhood leukemia. Curr Opin Hematol 2000; 7: 217-2.
4. Sonmezer M und Oktay K: Fertility preservation in female patients. Human Reproduction Update 2004; 10: 251-66.
5. Oktay K, Kan MT und Rosenwaks Z: Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol 2001; 13: 263-8.
6. Familiari G, Caggiati A, Nottola SA et al.: Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 1993; 8: 2080-7.
7. Byrne J, Fears TR, Gail MH et al., Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788-93.
8. Meirow D, Lewis H, Nugent D, Epstein M: Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999; 14: 1903-7.
9. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988; 259: 2123-5.
10. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN: Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003; 88: 5307-14.
11. Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ: Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum Reprod 1997; 12: 2483-8.
12. Howell S und Shalet S: Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27: 927-43.
13. Wallace WH, Thomson AB, Kelsey TW: The radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117-21.
14. Meirow D, Nugent D: The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7: 535-43.
15. Ray GR, Trueblood HW, Enright LP, Kaplan HS, Nelsen TS: Oophoropexy: a means of preserving ovarian function following pelvic mega-voltage radiotherapy for Hodgkin's disease. Radiology 1970; 96: 175-80.
16. Morice P, Thiam-Ba R, Castaigne D et al.: Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy. Hum Reprod 1998; 13: 660-3.
17. LeFloch O, Donaldson SS, Kaplan HS: Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer 1976; 38: 2263-8.
18. von Wolff M, Esenhard S, Strowitzki I: Ovarielle Protektion und Erhalt der Fertilität im Rahmen der Therapie gynäkologischer Malignome bei Kinderwunsch. Gynakol Endokr 2005; 3: 107-14.
19. Chen C: Pregnancy after human oocyte cryopreservation. Lancet 1986; 19 (8486): 884-6.
20. Mikkelsen AL: Strategies in human in-vitro maturation and their clinical outcome. Reprod Biomed Online. 2005; 10: 593-9.
21. von Otte S, Schöpper B, Al Hasani S, Diedrich K: In-vitro-Maturation: Eine Perspektive der assistierten Reproduktion. Der Gynäkologe 2004; 8: 701-9.
22. Donnez J, Dolmans MM, Demylle D et al.: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-10.
23. Oktay K, Buyuk E, Veeck L et al.: Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 363: 837-40.
24. Ataya K, Rao LV, Lawrence E, Kimmel R: Luteinizing hormone releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995; 52: 365-72.
25. Gerber B, Friedrich M, Maass N, Felberbaum R, von Minckwitz G, Ortmann O: Ovarprotektion mit GnRH-Analoga: Bereits ein Standard? Frauenarzt 2005; 10: 880-5.